article thumbnail

Editor's corner: Fierce Pharma's top 10 stories of 2022

Fierce Pharma

Editor's corner: Fierce Pharma's top 10 stories of 2022. Wed, 12/21/2022 - 08:42. esagonowsky.

Pharma 264
article thumbnail

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access

Fierce Pharma

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access. Thu, 12/15/2022 - 10:51.

Pharma 299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How pharma marketing must adapt to patient personalization

Fierce Pharma

How pharma marketing must adapt to patient personalization. Thu, 11/10/2022 - 18:32.

Marketing 263
article thumbnail

2023 forecast: FDA revamps cancer drug approvals, and Big Pharma is willing to fall in line

Fierce Pharma

2023 forecast: FDA revamps cancer drug approvals, and Big Pharma is willing to fall in line. Sun, 12/18/2022 - 17:18.

Pharma 290
article thumbnail

In another leadership change at Roche, Anderson departs as pharma CEO

Fierce Pharma

In another leadership change at Roche, Anderson departs as pharma CEO. Mon, 12/12/2022 - 09:25.

Pharma 262
article thumbnail

Thea Pharma gets FDA nod for preservative-free rival to Sun and Viatris glaucoma eye drops

Fierce Pharma

Thea Pharma gets FDA nod for preservative-free rival to Sun and Viatris glaucoma eye drops. Tue, 12/20/2022 - 04:53.

Pharma 278
article thumbnail

Leo Pharma scores with its JAK inhibitor cream in chronic hand eczema trial

Fierce Pharma

Leo Pharma scores with its JAK inhibitor cream in chronic hand eczema trial. Tue, 12/06/2022 - 10:04.

Pharma 259